Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

By Wei Shu-zhen  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 315-321

Humana Press, Inc

Access to resources Recommend Favorite

Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

By Lee Chee Khoon   Brown Chris   Gralla Richard J.   Hirsh Vera   Thongprasert Sumitra   Tsai Chun-Ming   Tan Eng Huat   Ho James Chung-Man   Chu Da Tong   Zaatar Adel   Osorio Sanchez Jemela Anne   Vu Vu Van   Au Joseph Siu Kie   Inoue Akira   Lee Siow Ming   Gebski Val   Yang James Chih-Hsin  

Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. : 595-605

Oxford University Press

Access to resources Recommend Favorite

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Cao Chao   Wang Jianmiao   Bunjhoo Hansvin   Xu Yongjian   Fang Huijuan  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

By  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1133-1133

Oxford University Press

Access to resources Recommend Favorite

Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis

By        

Biomedical Reports, Vol. 3, Iss. 4, 2015-01 ,pp. : 559-565

Science Publishers

Access to resources Recommend Favorite